LTF and COVID-19: Our results show that a daily 800 mg dose of bovine lactoferrin vs. placebo administered in combination with standard COVID-19 therapy could neither mitigate disease evolution (i.e., the prevention of death or ICU transfer) nor support clinical recovery.